Beta Bionics Inc
BBNX16.348USD
-0.052-0.32%
交易中 （美東）報價延遲15分鐘
700.67M總市值
虧損本益比TTM
關於 Beta Bionics Inc 公司
Beta Bionics, Inc. 是一家商業階段的醫療器械公司，致力於設計、開發和商業化各種解決方案，以改善需要胰島素的糖尿病患者 (PWD) 的健康。該公司的產品 iLet Bionic Pancreas (iLet) 是一種胰島素輸送裝置，經美國食品藥品管理局 (FDA) 批准，利用自適應閉環算法自主確定每次胰島素劑量，而無需用戶計算碳水化合物攝入量。iLet 用於治療 1 型糖尿病 (T1D)。該公司的解決方案包括成人版 iLet、兒童版 iLet、Bionic Circle App 和 iLet Simulator。該公司正處於開發胰島素泵的早期階段，該泵旨在直接粘附在皮膚上並無需導管即可給藥，在糖尿病行業中通常稱爲貼片泵。它還處於開發 iLet 雙激素配置的早期階段。
公司簡介
公司代碼BBNX
公司名稱Beta Bionics Inc
上市日期Jan 30, 2025
CEOMr. Sean Saint
員工數量291
證券類型Ordinary Share
年結日Jan 30
公司地址11 Hughes
城市IRVINE
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編92618
電話19494277785
網址https://www.betabionics.com
公司代碼BBNX
上市日期Jan 30, 2025
CEOMr. Sean Saint
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Steven Russell, M.D., Ph.D.
Dr. Steven Russell, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
72.03K
-1.42%
Ms. Christy Jones
Ms. Christy Jones
Independent Director
Independent Director
59.44K
--
Mr. Gerard J. Michel
Mr. Gerard J. Michel
Independent Director
Independent Director
12.55K
--
Mr. Adam Lezack
Mr. Adam Lezack
Independent Chairman of the Board
Independent Chairman of the Board
11.25K
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
Independent Director
Independent Director
11.25K
--
Mr. Sean D. Carney
Mr. Sean D. Carney
Independent Director
Independent Director
11.25K
--
Mr. Blake Beber
Mr. Blake Beber
Investor Relations
Investor Relations
--
--
Mr. Sean Saint
Mr. Sean Saint
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Dan Dearen
Mr. Dan Dearen
Independent Director
Independent Director
--
--
Mr. Stephen Feider
Mr. Stephen Feider
Chief Financial Officer
Chief Financial Officer
--
-100.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Steven Russell, M.D., Ph.D.
Dr. Steven Russell, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
72.03K
-1.42%
Ms. Christy Jones
Ms. Christy Jones
Independent Director
Independent Director
59.44K
--
Mr. Gerard J. Michel
Mr. Gerard J. Michel
Independent Director
Independent Director
12.55K
--
Mr. Adam Lezack
Mr. Adam Lezack
Independent Chairman of the Board
Independent Chairman of the Board
11.25K
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
Independent Director
Independent Director
11.25K
--
Mr. Sean D. Carney
Mr. Sean D. Carney
Independent Director
Independent Director
11.25K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2024
FY2023
業務USD
名稱
營收
佔比
DME channel - iLet
46.62M
71.58%
DME channel - Single-use products
12.19M
18.72%
PBP channel - Single-use products
4.22M
6.48%
PBP channel - iLet
2.10M
3.22%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
DME channel - iLet
46.62M
71.58%
DME channel - Single-use products
12.19M
18.72%
PBP channel - Single-use products
4.22M
6.48%
PBP channel - iLet
2.10M
3.22%
股東統計
更新時間: 8月2日 週六
更新時間: 8月2日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Eventide Asset Management, LLC
11.34%
Wellington Management Company, LLP
8.98%
Soleus Capital Management, L.P.
7.81%
Farallon Capital Management, L.L.C.
7.67%
RTW Investments L.P.
7.59%
Other
56.62%
持股股東
持股股東
佔比
Eventide Asset Management, LLC
11.34%
Wellington Management Company, LLP
8.98%
Soleus Capital Management, L.P.
7.81%
Farallon Capital Management, L.L.C.
7.67%
RTW Investments L.P.
7.59%
Other
56.62%
股東類型
持股股東
佔比
Hedge Fund
34.04%
Investment Advisor/Hedge Fund
30.34%
Investment Advisor
24.42%
Individual Investor
6.51%
Private Equity
5.08%
Research Firm
3.36%
Venture Capital
1.15%
Bank and Trust
0.03%
Insurance Company
0.01%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
160
45.51M
104.69%
+25.17M
2025Q1
149
45.45M
104.86%
+26.05M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Eventide Asset Management, LLC
4.93M
11.37%
+70.98K
+1.46%
Mar 31, 2025
Wellington Management Company, LLP
3.90M
9%
+3.90M
--
Mar 31, 2025
Soleus Capital Management, L.P.
3.40M
7.83%
+1.10M
+47.92%
Mar 31, 2025
Farallon Capital Management, L.L.C.
3.33M
7.69%
+55.00K
+1.68%
Mar 31, 2025
RTW Investments L.P.
3.30M
7.61%
+200.68K
+6.48%
Mar 31, 2025
Sands Capital Ventures LLC
3.15M
7.28%
+50.63K
+1.63%
Apr 02, 2025
Perceptive Advisors LLC
2.20M
5.08%
+2.20M
--
Mar 31, 2025
Omega Fund Management, LLC
1.99M
4.59%
+294.37K
+17.38%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.39M
3.22%
+1.39M
--
Mar 31, 2025
Holocene Advisors, LP
1.11M
2.56%
+1.11M
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Goldman Sachs Innovate Equity ETF
0.05%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Broad Market ETF
0%
iShares Russell 2000 Value ETF
0%
查看更多
Goldman Sachs Innovate Equity ETF
佔比0.05%
Proshares Ultra Russell 2000
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Schwab U.S. Broad Market ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
